113 related articles for article (PubMed ID: 33946014)
1. CCN3 Proteins as a diagnostic marker in osteosarcoma patients: A case control study.
Siddiqui S; Pandey V; Ali S; Singh A; Sharma D; Yadav M; Raikwar A
Cancer Treat Res Commun; 2021; 28():100381. PubMed ID: 33946014
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
3. CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis.
Dankner M; Ouellet V; Communal L; Schmitt E; Perkins D; Annis MG; Barrès V; Caron C; Mes-Masson AM; Saad F; Siegel PM;
Am J Pathol; 2019 Jul; 189(7):1451-1461. PubMed ID: 31202437
[TBL] [Abstract][Full Text] [Related]
4. Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma.
Lammli J; Fan M; Rosenthal HG; Patni M; Rinehart E; Vergara G; Ablah E; Wooley PH; Lucas G; Yang SY
Int Orthop; 2012 Nov; 36(11):2307-13. PubMed ID: 22855059
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma.
Bao ZQ; Zhang CC; Xiao YZ; Zhou JS; Tao YS; Chai DM
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):193-199. PubMed ID: 27072961
[TBL] [Abstract][Full Text] [Related]
6. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
Davis JL; Horvai AE
Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of CCN3 in Ewing sarcoma.
Perbal B; Lazar N; Zambelli D; Lopez-Guerrero JA; Llombart-Bosch A; Scotlandi K; Picci P
Hum Pathol; 2009 Oct; 40(10):1479-86. PubMed ID: 19695675
[TBL] [Abstract][Full Text] [Related]
8. The expression of ccn3(nov) gene in musculoskeletal tumors.
Manara MC; Perbal B; Benini S; Strammiello R; Cerisano V; Perdichizzi S; Serra M; Astolfi A; Bertoni F; Alami J; Yeger H; Picci P; Scotlandi K
Am J Pathol; 2002 Mar; 160(3):849-59. PubMed ID: 11891184
[TBL] [Abstract][Full Text] [Related]
9. Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma.
Kobayashi E; Masuda M; Nakayama R; Ichikawa H; Satow R; Shitashige M; Honda K; Yamaguchi U; Shoji A; Tochigi N; Morioka H; Toyama Y; Hirohashi S; Kawai A; Yamada T
Mol Cancer Ther; 2010 Mar; 9(3):535-44. PubMed ID: 20159990
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma of the patella. A case report.
Nagai S; Okuda N; Azuma H; Suzuki M; Takahama M
Clin Orthop Relat Res; 1993 Apr; (289):243-6. PubMed ID: 8472423
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic correlation of vitamin D receptor expression with retinoid X receptor and MIB-1 expression in primary and metastatic osteosarcoma.
Gallagher R; Keighley J; Tancabelic J; Garimella R; Pinson D; Templeton K; Tawfik O
Ann Diagn Pathol; 2012 Oct; 16(5):323-9. PubMed ID: 22542077
[TBL] [Abstract][Full Text] [Related]
13. [Primary osteosarcoma of the thigh: about a case].
Traoré BZ; Benmansour A; Saoud O; El Aboudi S; Bouktab A
Pan Afr Med J; 2015; 20():210. PubMed ID: 26113941
[TBL] [Abstract][Full Text] [Related]
14. Strong expression of paired-like homeodomain transcription factor 1 (PITX1) is associated with a favorable outcome in human osteosarcoma.
Kong G; Liu Z; Wu K; Zhang Y; Deng Z; Feng W; Chen S; Wang H
Tumour Biol; 2015 Sep; 36(10):7735-41. PubMed ID: 25936343
[TBL] [Abstract][Full Text] [Related]
15. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
Jiang L; Liu J; Wei Q; Wang Y
Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
[TBL] [Abstract][Full Text] [Related]
16. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
17. p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.
Li Y; Nakka M; Kelly AJ; Lau CC; Krailo M; Barkauskas DA; Hicks JM; Man TK
Cancer Res; 2016 Jul; 76(13):4002-11. PubMed ID: 27197201
[TBL] [Abstract][Full Text] [Related]
18. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
19. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.
Rastogi S; Kumar R; Sankineani SR; Marimuthu K; Rijal L; Prakash S; Jalan D; Khan SA; Sharma MC
Int Orthop; 2012 Nov; 36(11):2315-21. PubMed ID: 23015149
[TBL] [Abstract][Full Text] [Related]
20. Primary osteosarcoma of the sphenoid bone with extensive periosteal extension--case report.
Hayashi T; Kuroshima Y; Yoshida K; Kawase T; Ikeda E; Mukai M
Neurol Med Chir (Tokyo); 2000 Aug; 40(8):419-22. PubMed ID: 10979265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
